Of these additional genes, the higher expression of four genes (BMP2, RPL18A, RPL19, and RPS12) was also significantly associated with better survival and delayed tumor recurrence in patients with glioma, especially those with grade III glioma. The gene discussed is BMP2; the disease is glioma.